Maybe 40% of U.S. health care spending is tied to obesity. So this is a big problem. That's what Lilly's for. And tirzepatide ...

Operator Ladies and gentlemen, thank you for standing by and welcome to the Lilly Q3 2024 earnings call. [Operator ...

The move comes after the FDA took tirzepatide, the key ingredient in Eli Lilly’s (LLY ... Anjalee Khemlani is the senior ...

Read an update on dividend stocks with strong growth potential and resilience, perfect for navigating election volatility and ...

US drug shortages have decreased from 323 to 277 as of September 2024, yet many essential drugs remain scarce, with 50% of ...

Drugs like Wegovy may trim your waistline but not medical costs, according to an analysis of U.S. health insurance claims ...

BioNTech said that it is acquiring the Chinese drugmaker Biotheus for $800 million to bolster its cancer strategy. The two ...

There would also be collaboration on "new and innovative ways of delivering health and care services," according to a Lilly statement ... The AI effect in pharma commercial strategy: From data ...

Most U.S. states do not currently cover highly sought after weight-loss drugs from Novo Nordisk and Eli Lilly in their ...

sold as Lilly's Mounjaro and Zepbound. It's unknown exactly how many people are taking a compounded GLP-1, but one estimate puts the number at up to 2 million patients in the U.S., KFF Health News ...

This flawless execution allows us to advance toward the next important milestones of submitting the BLA and MAA in Q1 of 2025 and keeps us on track to have our first commercial launch ... of ...

US Senators are concerned that Pfizer and Eli Lilly's recent forays into direct ... that can increase spending for federal health care programmes." Lilly made the first move in this direction ...